Risk of malignancy with long-term immunosuppression in ANCA-associated vasculitis

被引：0

作者：

Rahmattulla, C. ^{[1
]}

Goceroglu, A. ^{[1
]}

Reinders, M. E. J. ^{[2
]}

Hagen, E. C. ^{[3
]}

Bruijn, J. A. ^{[1
]}

Bajema, I. M. ^{[1
]}

机构：

[1] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands

[2] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands

[3] Meander Med Ctr Amersfoort, Dept Nephrol, Amersfoort, Netherlands

来源：

PRESSE MEDICALE | 2013年 / 42卷 / 04期

关键词：

D O I：

10.1016/j.lpm.2013.02.273

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：767 / 767

页数：1

共 2 条

[1] Long-term patient survival in ANCA-associated vasculitis [J].

Flossmann, Oliver ;

Berden, Annelies ;

de Groot, Kirsten ;

Hagen, Chris ;

Harper, Lorraine ;

Heijl, Caroline ;

Hoglund, Peter ;

Jayne, David ;

Luqmani, Raashid ;

Mahr, Alfred ;

Mukhtyar, Chetan ;

Pusey, Charles ;

Rasmussen, Niels ;

Stegeman, Coen ;

Walsh, Michael ;

Westman, Kerstin .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (03) :488-494

[2] Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials [J].

Heijl, C. ;

Harper, L. ;

Flossmann, O. ;

Stucker, I. ;

Scott, D. G. I. ;

Watts, R. A. ;

Hoglund, P. ;

Westman, K. ;

Mahr, A. .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (08) :1415-1421

← 1 →